{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:23:28Z","timestamp":1783981408307,"version":"3.55.0"},"reference-count":148,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Postacute sequelae of SARS-CoV-2 infection (PASC), or Long COVID, is estimated to affect over 60 million individuals globally, with almost half of COVID-19 survivors experiencing persistent symptoms such as neuropathic pain, fatigue, and autonomic dysfunction. Despite its prevalence, the pathophysiology of PASC remains poorly understood. This narrative review highlights activation of mast cells (MCs), the unique tissue immune cells as a central contributor to neuropathic manifestations in PASC. Mast cell locations near nerves and vessels allows them to regulate neuroimmune and neurovascular processes. Mast cell activation mirrors patterns seen in small-fiber neuropathy and myalgic encephalomyelitis\/chronic fatigue syndrome, suggesting a shared immune-mediated etiology. The SARS-CoV-2 spike protein has been shown to activate MCs via angiotensin-converting enzyme 2 and toll-like receptor 4, triggering release of pro-inflammatory and neurotoxic mediators, including interleukin-1\u03b2, interleukin-6, tumor necrosis factor alpha, histamine, and tryptase. Such mediators sensitize peripheral nerves, disrupt the blood-brain barrier, and recruit microglia, ultimately contributing to small-fiber injury, neuroinflammation, and dysautonomia. Emerging reports suggest benefit from MC-directed treatments although responses remain variable. Understanding the role of MCs in PASC may offer a plausible mechanism of pathogenesis and guide targeted therapies. Future studies are needed to validate these findings and improve PASC patient outcomes.<\/jats:p>","DOI":"10.1093\/jnen\/nlag016","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:45:05Z","timestamp":1771418705000},"page":"413-424","source":"Crossref","is-referenced-by-count":1,"title":["Long COVID neuropathy: The role of mast cells"],"prefix":"10.1093","volume":"85","author":[{"given":"Zachary L","family":"Morcos","sequence":"first","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University , Ft. Lauderdale, FL,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-460X","authenticated-orcid":false,"given":"Theoharis C","family":"Theoharides","sequence":"additional","affiliation":[{"name":"Institute for Neuro-Immune Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University , Ft. Lauderdale, FL,","place":["United States"]},{"name":"Department of Immunology, Tufts University School of Medicine , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"2026042915365985300_nlag016-B1","author":"World Health Organization","year":"2021"},{"key":"2026042915365985300_nlag016-B2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2026042915365985300_nlag016-B3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.24095\/hpcdp.45.6.06","article-title":"Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence","volume":"45","author":"Taher","year":"2025","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"2026042915365985300_nlag016-B4","doi-asserted-by":"publisher","first-page":"ofaf533","DOI":"10.1093\/ofid\/ofaf533","article-title":"Global prevalence of long COVID, its subtypes and risk factors: an updated systematic review and meta-analysis","volume":"12","author":"Hou","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026042915365985300_nlag016-B5","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026042915365985300_nlag016-B6","author":"Cleveland Clinic"},{"key":"2026042915365985300_nlag016-B7","author":"Yale Medicine"},{"key":"2026042915365985300_nlag016-B8","author":"Mayo Clinic"},{"key":"2026042915365985300_nlag016-B9","doi-asserted-by":"crossref","first-page":"e071050","DOI":"10.1136\/bmj-2022-071050","article-title":"Post-acute sequelae of covid-19 six to 12 months after infection: population based study","volume":"379","author":"Peter","year":"2022","journal-title":"BMJ"},{"key":"2026042915365985300_nlag016-B10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/acn3.51496","article-title":"Long COVID-19: objectifying most self-reported neurological symptoms","volume":"9","author":"Bungenberg","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026042915365985300_nlag016-B11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acn3.51350","article-title":"Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \u201clong haulers\u201d","volume":"8","author":"Graham","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2026042915365985300_nlag016-B12","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","article-title":"Long covid defined","volume":"391","author":"Ely","year":"2024","journal-title":"N Engl J Med"},{"key":"2026042915365985300_nlag016-B13","first-page":"1","article-title":"Musculoskeletal involvement: COVID-19 and post COVID 19","volume":"69","author":"Evcik","year":"2023","journal-title":"Turk J Phys Med Rehabil"},{"key":"2026042915365985300_nlag016-B14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/acn3.51557","article-title":"Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: a cross-sectional study","volume":"9","author":"Eldokla","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026042915365985300_nlag016-B15","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/acn3.51631","article-title":"Genetics of COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome: a systematic review","volume":"9","author":"Tziastoudi","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026042915365985300_nlag016-B16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.23812\/20-EDIT3","article-title":"COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome","volume":"34","author":"Theoharides","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"2026042915365985300_nlag016-B17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ejp.1876","article-title":"Insight into pain syndromes in acute phase of mild-to-moderate COVID-19: frequency, clinical characteristics, and associated factors","volume":"26","author":"Oguz-Akarsu","year":"2022","journal-title":"Eur J Pain"},{"key":"2026042915365985300_nlag016-B18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/1756-185X.14409","article-title":"Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infection","volume":"25","author":"Saif","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"2026042915365985300_nlag016-B19","doi-asserted-by":"publisher","author":"Maguire","DOI":"10.1101\/2025.03.04.25323101"},{"key":"2026042915365985300_nlag016-B20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2012.00185","article-title":"TLR signaling in mast cells: common and unique features","volume":"3","author":"Sandig","year":"2012","journal-title":"Front Immunol"},{"key":"2026042915365985300_nlag016-B21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1172\/JCI0214704","article-title":"Differential responses of mast cell toll-like receptors 2 and 4 in allergy and innate immunity","volume":"109","author":"Supajatura","year":"2002","journal-title":"J Clin Invest"},{"key":"2026042915365985300_nlag016-B22","doi-asserted-by":"crossref","first-page":"9487","DOI":"10.3390\/ijms24119487","article-title":"Recombinant SARS-CoV-2 spike protein stimulates secretion of chymase, tryptase, and IL-1\u03b2 from human mast cells, augmented by IL-33","volume":"24","author":"Tsilioni","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026042915365985300_nlag016-B23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41392-021-00849-0","article-title":"SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026042915365985300_nlag016-B24","doi-asserted-by":"crossref","first-page":"e00078-25","DOI":"10.1128\/jvi.00078-25","article-title":"Spike proteins of coronaviruses activate mast cells for degranulation via stimulating Src\/PI3K\/AKT\/Ca2+ intracellular signaling Cascade","volume":"99","author":"Zhang","year":"2025","journal-title":"J Virol"},{"key":"2026042915365985300_nlag016-B25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.anai.2020.11.003","article-title":"Potential association of mast cells with coronavirus disease 2019","volume":"126","author":"Theoharides","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026042915365985300_nlag016-B26","doi-asserted-by":"crossref","first-page":"574862","DOI":"10.3389\/fimmu.2020.574862","article-title":"Mast cells in alveolar septa of COVID-19 patients: a pathogenic pathway that may link interstitial edema to immunothrombosis","volume":"11","author":"Motta Junior","year":"2020","journal-title":"Front Immunol"},{"key":"2026042915365985300_nlag016-B27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/acn3.70019","article-title":"Unleashing the power of multiomics: unraveling the molecular landscape of peripheral neuropathy","volume":"12","author":"Choi","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"2026042915365985300_nlag016-B28","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1212\/NXI.0000000000001146","article-title":"Peripheral neuropathy evaluations of patients with prolonged long COVID","volume":"9","author":"Oaklander","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026042915365985300_nlag016-B29","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1097\/j.pain.0000000000003259","article-title":"Small fibre neuropathy frequently underlies the painful long-COVID syndrome","volume":"165","author":"Falco","year":"2024","journal-title":"Pain"},{"key":"2026042915365985300_nlag016-B30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/mus.27458","article-title":"Small fiber neuropathy associated with SARS-CoV-2 infection","volume":"65","author":"Abrams","year":"2022","journal-title":"Muscle Nerve"},{"key":"2026042915365985300_nlag016-B31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jtos.2021.10.010","article-title":"Small fiber neuropathy in the cornea of covid-19 patients associated with the generation of ocular surface disease","volume":"23","author":"Barros","year":"2022","journal-title":"Ocul Surf"},{"key":"2026042915365985300_nlag016-B32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/jpm12040563","article-title":"Small fibre peripheral alterations following COVID-19 detected by corneal confocal microscopy","volume":"12","author":"Midena","year":"2022","journal-title":"J Pers Med"},{"key":"2026042915365985300_nlag016-B33","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1007\/s10072-022-06423-y","article-title":"Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome","volume":"43","author":"Novak","year":"2022","journal-title":"Neurol Sci"},{"key":"2026042915365985300_nlag016-B34","doi-asserted-by":"crossref","first-page":"100276","DOI":"10.1016\/j.ensci.2020.100276","article-title":"Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report","volume":"21","author":"Novak","year":"2020","journal-title":"eNeurologicalSci"},{"key":"2026042915365985300_nlag016-B35","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.3390\/ijerph20064918","article-title":"A case of autoimmune small fiber neuropathy as possible post COVID sequelae","volume":"20","author":"Panagiotides","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026042915365985300_nlag016-B36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000524205","article-title":"Small-fiber neuropathy possibly associated with COVID-19","volume":"14","author":"Burakgazi","year":"2022","journal-title":"Case Rep Neurol"},{"key":"2026042915365985300_nlag016-B37","doi-asserted-by":"crossref","first-page":"e200244","DOI":"10.1212\/NXI.0000000000200244","article-title":"Case-control study of individuals with small fiber neuropathy after COVID-19","volume":"11","author":"McAlpine","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026042915365985300_nlag016-B38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/jpm14080789","article-title":"Small fiber neuropathy associated with post-COVID-19 and post-COVID-19 vaccination arthritis: a rare post-infective syndrome or a new-onset disease?","volume":"14","author":"Bandinelli","year":"2024","journal-title":"J Pers Med"},{"key":"2026042915365985300_nlag016-B39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/practneurol-2013-000758","article-title":"The clinical approach to small fibre neuropathy and painful channelopathy","volume":"14","author":"Themistocleous","year":"2014","journal-title":"Pract Neurol"},{"key":"2026042915365985300_nlag016-B40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jnen\/nlac085","article-title":"Skin biopsy as a novel diagnostic aid in immune-mediated neuropathies","volume":"81","author":"Min","year":"2022","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026042915365985300_nlag016-B41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10286-021-00803-8","article-title":"Autonomic dysfunction following COVID-19 infection: an early experience","volume":"31","author":"Shouman","year":"2021","journal-title":"Clin Auton Res"},{"key":"2026042915365985300_nlag016-B42","first-page":"e43600","article-title":"Small fiber neuropathy after SARS-CoV-2 infection and vaccination: a case-based comparison","volume":"15","author":"Schwartz","year":"2023","journal-title":"Cureus"},{"key":"2026042915365985300_nlag016-B43","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1186\/s12967-023-04678-3","article-title":"Dysautonomia and small fiber neuropathy in post-COVID condition and chronic fatigue syndrome","volume":"21","author":"Azcue","year":"2023","journal-title":"J Transl Med"},{"key":"2026042915365985300_nlag016-B44","doi-asserted-by":"crossref","first-page":"e240178","DOI":"10.1136\/bcr-2020-240178","article-title":"Late onset of Guillain-Barr\u00e9 syndrome following SARS-CoV-2 infection: part of \u2018long COVID-19 syndrome\u2019?","volume":"14","author":"Raahimi","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2026042915365985300_nlag016-B45","first-page":"e2401","article-title":"Bulbar onset amyotrophic lateral sclerosis in a COVID-19 patient: a case report","volume":"15","author":"Abu-Abaa","year":"2023","journal-title":"Cureus"},{"key":"2026042915365985300_nlag016-B46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/pcn.13855","article-title":"Neuroimmune pathophysiology of long COVID","volume":"79","author":"Moen","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"2026042915365985300_nlag016-B47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","article-title":"Mast cells and inflammation","volume":"1822","author":"Theoharides","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2026042915365985300_nlag016-B48","doi-asserted-by":"publisher","first-page":"100003","DOI":"10.1016\/j.allmed.2024.100003","article-title":"Mast cells: the unregulated master immune response conductor","volume":"1","author":"Theoharides","year":"2024","journal-title":"Allergy Medicine"},{"key":"2026042915365985300_nlag016-B49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.anai.2023.10.032","article-title":"Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation","volume":"132","author":"Theoharides","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026042915365985300_nlag016-B50","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.jaip.2023.03.015","article-title":"Research advances in mast cell biology and their translation into novel therapies for anaphylaxis","volume":"11","author":"Dispenza","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026042915365985300_nlag016-B51","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med"},{"key":"2026042915365985300_nlag016-B52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2023.2200936","article-title":"Mast cell activation: beyond histamine and tryptase","volume":"19","author":"Theoharides","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"2026042915365985300_nlag016-B53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-071719-094903","article-title":"Mast cells in inflammation and disease: recent progress and ongoing concerns","volume":"38","author":"Galli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"2026042915365985300_nlag016-B54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2024.05.025","article-title":"Mast cell activation syndrome: current understanding and research needs","volume":"154","author":"Castells","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2026042915365985300_nlag016-B55","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases","volume":"22","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2026042915365985300_nlag016-B56","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/cells12050688","article-title":"Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID","volume":"12","author":"Theoharides","year":"2023","journal-title":"Cells"},{"key":"2026042915365985300_nlag016-B57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijid.2021.09.043","article-title":"Mast cell activation symptoms are prevalent in Long-COVID","volume":"112","author":"Weinstock","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026042915365985300_nlag016-B58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fncel.2019.00353","article-title":"Mast cells, neuroinflammation and pain in fibromyalgia syndrome","volume":"13","author":"Theoharides","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"2026042915365985300_nlag016-B59","doi-asserted-by":"crossref","first-page":"176385","DOI":"10.1016\/j.ejphar.2024.176385","article-title":"Involvement of peripheral mast cells in a fibromyalgia model in mice","volume":"967","author":"Brum","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"2026042915365985300_nlag016-B60","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/j.pain.0000000000001304","article-title":"Dermal nerve fibre and mast cell density, and proximity of mast cells to nerve fibres in the skin of patients with complex regional pain syndrome","volume":"159","author":"Morellini","year":"2018","journal-title":"Pain"},{"key":"2026042915365985300_nlag016-B61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0404.1967.tb05739.x","article-title":"Degranulation of mast cells in peripheral nerve injuries","volume":"43","author":"Olsson","year":"1967","journal-title":"Acta Neurol Scand"},{"key":"2026042915365985300_nlag016-B62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0304-3959(03)00261-6","article-title":"Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells","volume":"105","author":"Zuo","year":"2003","journal-title":"Pain"},{"key":"2026042915365985300_nlag016-B63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S1740925X08000021","article-title":"Mast cells can contribute to axon-glial dissociation and fibrosis in peripheral nerve","volume":"3","author":"Monk","year":"2007","journal-title":"Neuron Glia Biol"},{"key":"2026042915365985300_nlag016-B64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0404.1971.tb07490.x","article-title":"Mast cells in human peripheral nerve","volume":"47","author":"Olsson","year":"1971","journal-title":"Acta Neurol Scand"},{"key":"2026042915365985300_nlag016-B65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000085653","article-title":"Upregulation of matrix metalloproteinases following nerve injury is not mediated by mast cell activation","volume":"12","author":"Zuo","year":"2005","journal-title":"Neuroimmunomodulation"},{"key":"2026042915365985300_nlag016-B66","first-page":"121","article-title":"Mast cells in human polyneuropathies: their density and regional distribution","volume":"9","author":"Knorr-Held","year":"1990","journal-title":"Clin Neuropathol"},{"key":"2026042915365985300_nlag016-B67","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2353\/ajpath.2006.060602","article-title":"Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice","volume":"169","author":"Kakurai","year":"2006","journal-title":"Am J Pathol"},{"key":"2026042915365985300_nlag016-B68","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"2026042915365985300_nlag016-B69","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1749-6632.1988.tb27227.x","article-title":"Role of mast cells in peripheral nervous system demyelination","volume":"540","author":"Johnson","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"2026042915365985300_nlag016-B70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/imr.12622","article-title":"Mast cell-neural interactions contribute to pain and itch","volume":"282","author":"Gupta","year":"2018","journal-title":"Immunol Rev"},{"key":"2026042915365985300_nlag016-B71","doi-asserted-by":"crossref","first-page":"eadh0545","DOI":"10.1126\/sciimmunol.adh0545","article-title":"Mast cell-derived BH4 and serotonin are critical mediators of postoperative pain","volume":"9","author":"Starkl","year":"2024","journal-title":"Sci Immunol"},{"key":"2026042915365985300_nlag016-B72","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.injury.2017.05.015","article-title":"Mast cells improve functional recovery of transected peripheral nerve: a novel preliminary study","volume":"48","author":"Ilkhanizadeh","year":"2017","journal-title":"Injury"},{"key":"2026042915365985300_nlag016-B73","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.anai.2021.10.006","article-title":"Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy","volume":"128","author":"Novak","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026042915365985300_nlag016-B74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00699233","article-title":"Galactose neuropathy. Permeability studies, mechanism of edema, and mast cell abnormalities","volume":"55","author":"Powell","year":"1981","journal-title":"Acta Neuropathol"},{"key":"2026042915365985300_nlag016-B75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00690588","article-title":"Change in mast cell dimensions increases the profile number in sections of peripheral nerve of diabetic rats","volume":"56","author":"Jakobsen","year":"1982","journal-title":"Acta Neuropathol"},{"key":"2026042915365985300_nlag016-B76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1556\/ABiol.54.2003.3-4.6","article-title":"Immunohistochemical analysis of substance P containing nerve fibres and their contacts with mast cells in the diabetic rat\u2019s tongue","volume":"54","author":"Batbayar","year":"2003","journal-title":"Acta Biol Hung"},{"key":"2026042915365985300_nlag016-B77","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1038\/s41467-025-59562-z","article-title":"Dysregulated mast cell activation induced by diabetic milieu exacerbates the progression of diabetic peripheral neuropathy in mice","volume":"16","author":"Yao","year":"2025","journal-title":"Nat Commun"},{"key":"2026042915365985300_nlag016-B78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1152\/jn.00239.2023","article-title":"A\u00e7a\u00ed berry ameliorates cognitive impairment by inhibiting NLRP3\/ASC\/CASP axis in STZ-induced diabetic neuropathy in mice","volume":"130","author":"Impellizzeri","year":"2023","journal-title":"J Neurophysiol"},{"key":"2026042915365985300_nlag016-B79","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2337\/db23-0862","article-title":"A neuron-mast cell axis regulates skin microcirculation in diabetes","volume":"73","author":"Li","year":"2024","journal-title":"Diabetes"},{"key":"2026042915365985300_nlag016-B80","doi-asserted-by":"crossref","first-page":"21261","DOI":"10.1038\/srep21261","article-title":"Identification of a prostaglandin D2 metabolite as a neuritogenesis enhancer targeting the TRPV1 ion channel","volume":"6","author":"Shibata","year":"2016","journal-title":"Sci Rep"},{"key":"2026042915365985300_nlag016-B81","doi-asserted-by":"crossref","first-page":"F298","DOI":"10.1152\/ajprenal.00435.2019","article-title":"Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H(1) receptor and TRPV1","volume":"318","author":"Grundy","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026042915365985300_nlag016-B82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.0906-6705.2004.0178.x","article-title":"Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures","volume":"13","author":"St\u00e4nder","year":"2004","journal-title":"Exp Dermatol"},{"key":"2026042915365985300_nlag016-B83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","article-title":"TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization","volume":"8","author":"Gouin","year":"2017","journal-title":"Protein Cell"},{"key":"2026042915365985300_nlag016-B84","doi-asserted-by":"crossref","first-page":"1358873","DOI":"10.3389\/fcimb.2024.1358873","article-title":"Mast cell activation triggered by SARS-CoV-2 causes inflammation in brain microvascular endothelial cells and microglia","volume":"14","author":"Wu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"2026042915365985300_nlag016-B85","doi-asserted-by":"crossref","first-page":"e300424229561","DOI":"10.2174\/0118715265319896240427045026","article-title":"SARS-CoV-2 or vaccinal spike protein can induce mast cell activation syndrome (MCAS)","volume":"25","author":"Fajloun","year":"2025","journal-title":"Infect Disord Drug Targets"},{"key":"2026042915365985300_nlag016-B86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00011-025-02032-5","article-title":"COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th(2) cytokines in a systemic mastocytosis patient","volume":"74","author":"Weiss-Tessbach","year":"2025","journal-title":"Inflamm Res"},{"key":"2026042915365985300_nlag016-B87","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/neurolint17010002","article-title":"Internal tremor in long COVID may be a symptom of dysautonomia and small fiber neuropathy","volume":"17","author":"Blitshteyn","year":"2024","journal-title":"Neurol Int"},{"key":"2026042915365985300_nlag016-B88","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/HJH.0000000000003669","article-title":"Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome","volume":"42","author":"Gonz\u00e1lez-Alvarez","year":"2024","journal-title":"J Hypertens"},{"key":"2026042915365985300_nlag016-B89","doi-asserted-by":"crossref","first-page":"1202696","DOI":"10.3389\/fcvm.2023.1202696","article-title":"Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation","volume":"10","author":"Salvucci","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026042915365985300_nlag016-B90","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijid.2022.02.049","article-title":"Successful treatment of a patient with severe COVID-19 using an integrated approach addressing mast cells and their mediators","volume":"118","author":"Theoharides","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2026042915365985300_nlag016-B91","first-page":"1538","article-title":"High free IgE and mast cell activation in long COVID: mechanisms of persistent immune dysregulation","volume":"15","author":"Genova","year":"2025","journal-title":"Life (Basel)"},{"key":"2026042915365985300_nlag016-B92","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pathophysiology32030036","article-title":"Post-COVID-19 femoral head osteonecrosis exhibits mast cell clusters, fibrosis, and vascular thrombosis: key pathological mechanisms in long COVID-19 bone degeneration","volume":"32","author":"Kuliyeva","year":"2025","journal-title":"Pathophysiology"},{"key":"2026042915365985300_nlag016-B93","doi-asserted-by":"crossref","first-page":"e13407","DOI":"10.1111\/sji.13407","article-title":"No signs of mast cell involvement in long-COVID: a case-control study","volume":"100","author":"Lenning","year":"2024","journal-title":"Scand J Immunol"},{"key":"2026042915365985300_nlag016-B94","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI mast cell disorders committee work group report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J Allergy Clin Immunl"},{"key":"2026042915365985300_nlag016-B95","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12931-022-02284-3","article-title":"Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients","volume":"23","author":"Budnevsky","year":"2022","journal-title":"Respir Res"},{"key":"2026042915365985300_nlag016-B96","doi-asserted-by":"crossref","first-page":"968981","DOI":"10.3389\/fimmu.2022.968981","article-title":"Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation","volume":"13","author":"Krysko","year":"2022","journal-title":"Front Immunol"},{"key":"2026042915365985300_nlag016-B97","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s00210-023-02545-y","article-title":"A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms","volume":"396","author":"Molderings","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2026042915365985300_nlag016-B98","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon","year":"2014","journal-title":"Front Immunol"},{"key":"2026042915365985300_nlag016-B99","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1091581818777754","article-title":"Inhibition of mast cell degranulation with cromolyn sodium exhibits organ-specific effects in polycystic kidney (PCK) rats","volume":"37","author":"Jiang","year":"2018","journal-title":"Int J Toxicol"},{"key":"2026042915365985300_nlag016-B100","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jaci.2014.10.032","article-title":"The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells","volume":"135","author":"Weng","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026042915365985300_nlag016-B101","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0091-6749(90)90067-E","article-title":"Cromolyn sodium in the management of systemic mastocytosis","volume":"85","author":"Horan","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"2026042915365985300_nlag016-B102","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/labinvest.2012.116","article-title":"Evidence questioning cromolyn\u2019s effectiveness and selectivity as a \u2018mast cell stabilizer\u2019 in mice","volume":"92","author":"Oka","year":"2012","journal-title":"Lab Invest"},{"key":"2026042915365985300_nlag016-B103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1476-5381.1987.tb08972.x","article-title":"Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol","volume":"90","author":"Church","year":"1987","journal-title":"Br J Pharmacol"},{"key":"2026042915365985300_nlag016-B104","doi-asserted-by":"crossref","first-page":"e33805","DOI":"10.1371\/journal.pone.0033805","article-title":"Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans","volume":"7","author":"Weng","year":"2012","journal-title":"PLoS One"},{"key":"2026042915365985300_nlag016-B105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000236122","article-title":"Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells","volume":"97","author":"Okayama","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"2026042915365985300_nlag016-B106","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1081-1206(10)63063-3","article-title":"Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells","volume":"79","author":"Yanni","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026042915365985300_nlag016-B107","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2133.2009.09516.x","article-title":"Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus","volume":"162","author":"Vieira Dos Santos","year":"2010","journal-title":"Br J Dermatol"},{"key":"2026042915365985300_nlag016-B108","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","article-title":"The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer","volume":"52","author":"Middleton","year":"2000","journal-title":"Pharmacol Rev"},{"key":"2026042915365985300_nlag016-B109","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3390\/molecules27092901","article-title":"Flavonoids as potential anti-inflammatory molecules: a review","volume":"27","author":"Al-Khayri","year":"2022","journal-title":"Molecules"},{"key":"2026042915365985300_nlag016-B110","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.3390\/molecules25225243","article-title":"Important flavonoids and their role as a therapeutic agent","volume":"25","author":"Ullah","year":"2020","journal-title":"Molecules"},{"key":"2026042915365985300_nlag016-B111","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1194\/jlr.M200292-JLR200","article-title":"Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress","volume":"44","author":"Balestrieri","year":"2003","journal-title":"J Lipid Res"},{"key":"2026042915365985300_nlag016-B112","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/jpet.117.240564","article-title":"Methoxyluteolin inhibits neuropeptide-stimulated proinflammatory mediator release via mTOR activation from human mast cells","volume":"361","author":"Patel","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"2026042915365985300_nlag016-B113","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2222.2000.00768.x","article-title":"Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells","volume":"30","author":"Kimata","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"2026042915365985300_nlag016-B114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-5-41","article-title":"Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression","volume":"5","author":"Rezai-Zadeh","year":"2008","journal-title":"J Neuroinflammation"},{"key":"2026042915365985300_nlag016-B115","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1073\/pnas.0802865105","article-title":"Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1","volume":"105","author":"Jang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042915365985300_nlag016-B116","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/rej.2015.1708","article-title":"Dietary luteolin reduces proinflammatory microglia in the brain of senescent mice","volume":"19","author":"Burton","year":"2016","journal-title":"Rejuvenation Res"},{"key":"2026042915365985300_nlag016-B117","doi-asserted-by":"crossref","first-page":"E7049","DOI":"10.1073\/pnas.1604992113","article-title":"Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism","volume":"113","author":"Patel","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042915365985300_nlag016-B118","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1159\/000537752","article-title":"Luteolin is more potent than cromolyn in their ability to inhibit mediator release from cultured human mast cells","volume":"185","author":"Tsilioni","year":"2024","journal-title":"Int Arch Allergy Immunol"},{"key":"2026042915365985300_nlag016-B119","doi-asserted-by":"crossref","first-page":"106403","DOI":"10.1016\/j.intimp.2020.106403","article-title":"Luteolin suppresses IL-31 production in IL-33-stimulated mast cells through MAPK and NF-\u03baB signaling pathways","volume":"83","author":"Che","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"2026042915365985300_nlag016-B120","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/ptr.7447","article-title":"Luteolin inhibits Fc\u03b5R\u0399- and MRGPRX2-mediated mast cell activation by regulating calcium signaling pathways","volume":"36","author":"Hao","year":"2022","journal-title":"Phytother Res"},{"key":"2026042915365985300_nlag016-B121","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12031-018-1094-2","article-title":"The flavone luteolin improves central nervous system disorders by different mechanisms: a review","volume":"65","author":"Ashaari","year":"2018","journal-title":"J Mol Neurosci"},{"key":"2026042915365985300_nlag016-B122","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/1389557519666190617150051","article-title":"The roles of flavonols\/flavonoids in neurodegeneration and neuroinflammation","volume":"20","author":"Calis","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"2026042915365985300_nlag016-B123","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/biof.1687","article-title":"Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma","volume":"47","author":"Kempuraj","year":"2021","journal-title":"Biofactors"},{"key":"2026042915365985300_nlag016-B124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/JCP.0000000000000084","article-title":"Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin","volume":"34","author":"Theoharides","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"2026042915365985300_nlag016-B125","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.acra.2020.04.035","article-title":"Neurologic involvement in COVID-19: radiologists\u2019 perspective","volume":"27","author":"Khalili","year":"2020","journal-title":"Acad Radiol"},{"key":"2026042915365985300_nlag016-B126","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1590\/S0100-879X2003001200002","article-title":"Neuroprotection by flavonoids","volume":"36","author":"Dajas","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"2026042915365985300_nlag016-B127","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuro.2016.05.008","article-title":"Luteolin protects the hippocampus against neuron impairments induced by kainic acid in rats","volume":"55","author":"Lin","year":"2016","journal-title":"Neurotoxicology"},{"key":"2026042915365985300_nlag016-B128","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1582-4934.2008.00344.x","article-title":"Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer\u2019s disease beta-amyloid production","volume":"13","author":"Rezai-Zadeh","year":"2009","journal-title":"J Cell Mol Med"},{"key":"2026042915365985300_nlag016-B129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fnins.2015.00225","article-title":"Brain \u201cfog,\u201d inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin","volume":"9","author":"Theoharides","year":"2015","journal-title":"Front Neurosci"},{"key":"2026042915365985300_nlag016-B130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s11064-018-2482-2","article-title":"Luteolin could improve cognitive dysfunction by inhibiting neuroinflammation","volume":"43","author":"Yao","year":"2018","journal-title":"Neurochem Res"},{"key":"2026042915365985300_nlag016-B131","doi-asserted-by":"crossref","first-page":"19409","DOI":"10.1038\/s41598-020-76160-9","article-title":"Dietary flavanols improve cerebral cortical oxygenation and cognition in healthy adults","volume":"10","author":"Gratton","year":"2020","journal-title":"Sci Rep"},{"key":"2026042915365985300_nlag016-B132","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-030-42667-5_7","article-title":"Polyphenols as an effective therapeutic intervention against cognitive decline during normal and pathological brain aging","volume":"1260","author":"Devi","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"2026042915365985300_nlag016-B133","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/biof.1726","article-title":"Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue","volume":"47","author":"Theoharides","year":"2021","journal-title":"Biofactors"},{"key":"2026042915365985300_nlag016-B134","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00415-021-10655-x","article-title":"Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex","volume":"269","author":"Hugon","year":"2022","journal-title":"J Neurol"},{"key":"2026042915365985300_nlag016-B135","doi-asserted-by":"publisher","DOI":"10.2174\/0118715249352790250711092129","article-title":"Role of morin & alpha-lipoic acid in diabetic neuropathic pain","author":"Wal","year":"2025","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2026042915365985300_nlag016-B136","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/ph17111538","article-title":"Effects of short-term treatment with \u03b1-lipoic acid on neuropathic pain and biomarkers of DNA damage in patients with diabetes mellitus","volume":"17","author":"Lazutka","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026042915365985300_nlag016-B137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/diagnostics15030353","article-title":"Current and evolving concepts in the management of complex regional pain syndrome: a narrative review","volume":"15","author":"Candan","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"2026042915365985300_nlag016-B138","first-page":"32","article-title":"A comprehensive review of safety, efficacy, and indications for the use of alpha-lipoic acid and acetyl-l-carnitine in neuropathic pain","volume":"23","author":"Aldendail","year":"2024","journal-title":"Integr Med (Encinitas)"},{"key":"2026042915365985300_nlag016-B139","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cns.13303","article-title":"Alpha-lipoic acid downregulates TRPV1 receptor via NF-\u03baB and attenuates neuropathic pain in rats with diabetes","volume":"26","author":"Zhang","year":"2020","journal-title":"CNS Neurosci Ther"},{"key":"2026042915365985300_nlag016-B140","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1111\/jcmm.17947","article-title":"The involvement of transient receptor potential channels in mast cell activation by microbubbles","volume":"27","author":"Liu","year":"2023","journal-title":"J Cell Mol Med"},{"key":"2026042915365985300_nlag016-B141","doi-asserted-by":"crossref","first-page":"e01384-25","DOI":"10.1128\/jvi.01384-25","article-title":"Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19","volume":"99","author":"Dette","year":"2025","journal-title":"J Virol"},{"key":"2026042915365985300_nlag016-B142","doi-asserted-by":"crossref","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"2026042915365985300_nlag016-B143","doi-asserted-by":"crossref","first-page":"e86002d","DOI":"10.7554\/eLife.86002","article-title":"Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"12","author":"Sherif","year":"2023","journal-title":"Elife"},{"key":"2026042915365985300_nlag016-B144","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12985-022-01891-2","article-title":"Pathophysiology of post-COVID syndromes: a new perspective","volume":"19","author":"Batiha","year":"2022","journal-title":"Virol J"},{"key":"2026042915365985300_nlag016-B145","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/infdis\/jiac017","article-title":"Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome","volume":"225","author":"Acosta-Ampudia","year":"2022","journal-title":"J Infect Dis"},{"key":"2026042915365985300_nlag016-B146","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2025.02.005","article-title":"Autoimmunity in long COVID","volume":"155","author":"Talwar","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"2026042915365985300_nlag016-B147","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.2174\/1381612829666221027114123","article-title":"Mast cell\u2019s role in cytokine release syndrome and related manifestations of COVID-19 disease","volume":"28","author":"\u00d6zdemir","year":"2022","journal-title":"Curr Pharm Des"},{"key":"2026042915365985300_nlag016-B148","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijid.2020.09.016","article-title":"Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome","volume":"100","author":"Afrin","year":"2020","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/85\/5\/413\/67260534\/nlag016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/85\/5\/413\/67260534\/nlag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:37:32Z","timestamp":1777491452000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/85\/5\/413\/8509447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":148,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,6]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlag016","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,6]]}}}